In this study, through bioinformatics analyses and in vitro experiments, we showed that activated cell cycle program was associated with immunosuppression, weakened immunotherapy efficiency, and worse prognosis in HCC patients, and that Birc5 was a potential biomarker and inducer of intratumor infiltration of MDSCs. Here, BIRC5 is linked to hepatocellular carcinoma.